Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD - Wikidata - awgldk - TriplyDB

Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD

Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD

http://www.wikidata.org/entity/Q35492192

about

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.

P2860

Q38598993-9E410799-ECC4-4DDF-986B-31DEA06CA867

P2860

Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD

http://www.wikidata.org/entity/Q35492192

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Role of the fixed combination ...... patients with asthma and COPD

@ast

Role of the fixed combination ...... patients with asthma and COPD

@en

type

label

Role of the fixed combination ...... patients with asthma and COPD

@ast

Role of the fixed combination ...... patients with asthma and COPD

@en

prefLabel

Role of the fixed combination ...... patients with asthma and COPD

@ast

Role of the fixed combination ...... patients with asthma and COPD

@en

P1433

Q35492192-300402DC-00DA-4F13-B8AA-3D24EFC5F342

P1476

Q35492192-A2EE017D-0C30-4220-ABC1-44B521B7CC45

P2093

Q35492192-E61AA075-E63D-48CA-85E7-C919ED1A51B1

Q35492192-FEE4E192-58CD-47BD-AA57-5CB3FEB6F7E9

P275

Q35492192-68E296A6-51E0-4AEB-9C39-25D7922FAC6B

P2860

Q35492192-02A1E59E-60C6-455E-BC53-4FA96222ED7F

Q35492192-087AFE11-158F-4DFA-BB8B-86013FC95473

Q35492192-0F204BFB-64D8-4B0C-BFCB-BA278AC765B9

Q35492192-10963499-F3FA-4D9C-95DE-A8A547722367

Q35492192-13F6E349-26CF-4EB6-92E7-E8DE9C4C61B7

Q35492192-187258F6-D0C5-49A2-BE0B-D9ED16B32A8A

Q35492192-1CD8F141-0FD3-49A2-B793-9477F2B023F4

Q35492192-1E895596-CA9D-4EBE-BF8D-7084A499DD79

Q35492192-2D3771D6-7E4E-4868-A65E-65E2351FED4F

Q35492192-2FCFB93C-5BF1-4C35-B953-B45D67E8E251

P304

Q35492192-36907527-D918-43F7-A4EA-84579556A2B9

P31

Q35492192-4DD217C4-F1D5-467B-87CD-3EA71CAE9222

Q35492192-E69D05BB-EC3B-4385-B787-C23D7BD3E329

P356

Q35492192-B366770E-9829-49C2-8D2F-A7A37EF9095D

P407

Q35492192-4B8CB70E-5EC8-4204-9CF6-8879E33EF09B

P478

Q35492192-680FD8BB-A392-4403-BA2C-3D8028CBAD03

P577

Q35492192-C8B0B81D-A620-43D9-8E16-96BEC4D43505

P5875

Q35492192-DFC53536-B2AB-4AA9-93B2-C822A8BB6E5E

P698

Q35492192-9014B3D0-550B-44B4-AF22-286DD634C2C6

P921

Q35492192-143DBC90-D02A-45EE-A319-7040CA9125EC

Q35492192-25B2DCD7-A91B-4D89-89AA-5AA24BBEA392

Q35492192-5A2F87DF-C9D3-4AA8-91E2-686D0A111945

Q35492192-6151C65C-C7B5-4F30-8168-327A3D2D6CFF

Q35492192-7E36B745-4DEE-4968-B06F-FD016C01F779

Q35492192-830B4B53-E66F-4F92-8E88-8EF6E8185D9E

Q35492192-9DD4B897-889F-4277-B306-B4C59EFC6200

Q35492192-CA979BD9-9860-468A-BAD5-9E97AB806E55

Q35492192-F52F6E62-47DB-4D6A-BAF6-3B7D482AF434

P932

Q35492192-7CC865BF-3388-4483-A14E-A708301CB084

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Role of the fixed combination ...... patients with asthma and COPD

@en

P2093

Jinming Gao

http://www.w3.org/2001/XMLSchema#string

Roy A Pleasants

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.

Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007.

Global asthma prevalence in adults: findings from the cross-sectional world health survey.

Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study.

The hygiene hypothesis in allergy and asthma: an update.

P304

775-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S80656

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275025726

http://www.w3.org/2001/XMLSchema#string

P698

25926729

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

mechanism of action

polycyclic compound

pharmaceutical preparation

Anagraw amesgunef

P932

4403740

http://www.w3.org/2001/XMLSchema#string